EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Sex-aware causal inference assessment of the immune system in complex neurodegenerative diseases

Frida Lona-Durazo iD, Ross P Byrne, Marc-Olivier Pilon, Michael D Greicius, Marie-Pierre Dubé, Michael E Belloy, Russell L McLaughlin iD, Sarah A Gagliano Taliun iD

Brain · 2025

DOI: 10.1093/brain/awaf474 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, 2025. Verfasst von Frida Lona-Durazo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Montréal Heart Institute, Montréal, QC H1T 1C8, Canada. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Sex Characteristics, Parkinson Disease, Immune System. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Alzheimer Society of Canada, CIHR, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sex differences, in terms of prevalence, symptoms and disease progression, are established in the etiology of complex neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson’s disease and Alzheimer’s disease, but the underlying biology driving these differences remains poorly understood. There is emerging evidence, through genetic and functional analyses, affirming the role of the immune system in such diseases, but a thorough assessment of sex differences linking the immune system and neurodegenerative diseases is understudied. Here, we applied a robust causal inference approach, two-sample Mendelian randomization, to evaluate the causal effect of immune-related protein levels on three neurodegenerative diseases with large-scale sex-stratified genome-wide association data available: amyotrophic lateral sclerosis (females = 10,895 cases, 57,062 controls; males = 15,547 cases, 50,145 controls), Parkinson’s disease (females = 7,947 cases, 90,662 controls; males = 13,020 cases, 89,660 controls) and Alzheimer’s disease (females = 18,822 cases, 281,415 controls; males = 17,293 cases, 213,339 controls). As exposures, we focused on 932 immune system-related proteins with significant protein cis-quantitative trait loci (FDR cutoff < 0.01) from a large sex-combined plasma protein dataset (N = 33,477), for which corresponding genes were included in the Immunology Database and Analysis Portal gene list. We tested for a causal relationship between genetically predicted levels of each of these proteins and each neurodegenerative disease in sex-stratified and sex-combined data, followed by colocalization and estimation of sex-differential effects. We additionally performed exploratory analyses using sex-combined CSF protein cis-quantitative trait loci (N = 971) as exposures. We observed evidence for a sex-differential causal relationship between FCGR2A and Parkinson’s disease, and between CD2AP, MAMDC2, PCDH17 or CSF3 and Alzheimer’s disease. We validated significant results using two independent protein cis-quantitative trait loci datasets for those plasma proteins available. After performing sensitivity analyses, we validated the potential causal relationships of OMG on Parkinson’s disease and of GRN, SERPINF2 and TREM2 on Alzheimer’s disease. Mendelian randomization with CSF protein cis-quantitative trait loci showed a potential causal effect of ADGRE2, GPNMB and COLEC11 on Parkinson’s disease and of CD33 on Alzheimer’s disease, without evidence of sex-differential effects. Finally, we substantiated our findings of protein-disease pairs using triangulation, specifically reporting independent supporting evidence from the literature and drug-related databases. Overall, our results point to potential causal effects of genetically predicted levels of immune system-related plasma and CSF proteins in Alzheimer’s disease and Parkinson’s disease, some of which may be considered as potential candidates for drug development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurodegenerative DiseasesSex CharacteristicsParkinson DiseaseImmune SystemHumansFemaleMaleGenome-Wide Association StudyMendelian Randomization AnalysisAlzheimer DiseaseAmyotrophic Lateral SclerosisGenetic Predisposition to Disease

Stichwörter der Autor:innen

Alzheimer’s diseaseMendelian randomizationParkinson’s diseaseamyotrophic lateral sclerosisimmune systemsex differential effects

Autor:innen und Institutionen

  • Montréal Heart Institute, Montréal, QC H1T 1C8, Canada.
  • Faculty of Medicine, Université de Montréal, Montréal, QC H3C 3J7, Canada.
  • Smurfit Institute of Genetics, Trinity College Dublin, Dublin, D02 DK07, Republic of Ireland.
  • Université de Montréal Beaulieu-Saucier Pharmacogenomics Centre, Montréal, QC H1T 1C8, Canada.
  • Faculty of Pharmacy, Université de Montréal, Montréal, QC H3T 1J4, Canada.
  • Neurology and Neurological Sciences, Standford University, Stanford, CA 94305, USA.

ORCID-Profile: Frida Lona-Durazo, Russell L McLaughlin, Sarah A Gagliano Taliun

Förderung

  • Alzheimer Society of Canada
  • CIHR
  • NIA NIH HHS
  • Research Ireland
  • MND association
  • FRQS
  • Fonds de Recherche du Québec
  • Canada Research Chairs Program

Zitieren

APA

Lona-Durazo, F., Byrne, R. P., Pilon, M. O., Greicius, M. D., Dubé, M. P., Belloy, M. E., McLaughlin, R. L., & Gagliano Taliun, S. A. (2025). Sex-aware causal inference assessment of the immune system in complex neurodegenerative diseases. Brain. https://doi.org/10.1093/brain/awaf474

Vancouver

Lona-Durazo F, Byrne RP, Pilon MO, Greicius MD, Dubé MP, Belloy ME, et al. Sex-aware causal inference assessment of the immune system in complex neurodegenerative diseases. Brain. 2025. doi:10.1093/brain/awaf474

BibTeX
@article{LonaDurazo2025,
  author = {Lona-Durazo, Frida and Byrne, Ross P and Pilon, Marc-Olivier and Greicius, Michael D and Dubé, Marie-Pierre and Belloy, Michael E and McLaughlin, Russell L and Gagliano Taliun, Sarah A},
  title = {Sex-aware causal inference assessment of the immune system in complex neurodegenerative diseases},
  journal = {Brain},
  year = {2025},
  doi = {10.1093/brain/awaf474}
}
Kostenlos starten →